Loading
Beijing Tiantan Biological Products Co., Ltd. Stock: price and insider trades · China
天坛生物
No insider purchase over the last 90 days. The latest, by 刘亚娜, was filed 19 Jan 2024.
Beijing Tiantan Biological Products Co., Ltd.: what insiders have been doing
Beijing Tiantan Biological Products Co., Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SSE / SZSE (CSRC). No insider at Beijing Tiantan Biological Products Co., Ltd. has published a filing in the past twelve months. The most recent one dates from 19 January 2024.
Since 2023, the database holds 5 purchases and no sales by insiders of the company.
Other companies in the same sector with recent insider buying flagged by our signals: MAIA Biotechnology, Inc. and Cooper Companies, Inc. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Insider Decl.
5
Thresholds
n/a
Buy Volume
€185,229
5 ops. · all time
Sell Volume
n/a
n/a
Since the insiders bought
- -12.8%Entry CN¥22.23 · Close at T+365 CN¥19.39
- -18.1%Entry CN¥23.39 · Close at T+365 CN¥19.15
- +13.3%Entry CN¥20.82 · Close at T+365 CN¥23.59
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Beijing Tiantan Biological Products Co., Ltd. Buy (bullish), based on 4 analysts. Average price target: CN¥16.85.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 8,433 of 26,330 companies
60.6
score / 100
Value48
Quality73
FCF yld-1.1%
Earn yld4.4%
EV/EBITDA11.1x
ROE6.8%
Gross mgn44%
Net mgn18%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CN¥12.59
Analyst consensus
4 analystsBuy
CN¥13.40Target CN¥16.85(+34%)CN¥24.00
Income statement
RevenueCN¥6.2B
Gross profitCN¥2.7B44% margin
EBITDACN¥2.3B37% margin
Net incomeCN¥1.1B13.4% margin
Valuation
PER (trailing)33.1x
PER (forward)30.6x
P/Book2.1x
Beta0.22
Balance sheet & cash
Market capCN¥24.9B
Total debtCN¥160.8M
Free Cash Flow-CN¥266.8M
Debt / Equity1%
Profitability & ownership
ROE6.8%
ROA4.7%
% insiders57.0%
% institutions3.2%
Last declaration on 19 January 2024
Declarations5 total
4,000 shares29.1% of flowA股XSHGSSE:173000007270051600
Canonical exit: 18 Apr 2024 (T+90)
9,600 shares70.9% of flowA股XSHGSSE:173000007258690660
Canonical exit: 15 Apr 2024 (T+90)
8,800 shares49.2% of flowA股XSHGSSE:173000007258690880
Canonical exit: 15 Apr 2024 (T+90)
22,600 shares100.0% of flowA股XSHGSSE:173000006924666370
Canonical exit: 7 Dec 2023 (T+90)
10,300 shares50.8% of flowA股XSHGSSE:173000006900608420
Canonical exit: 3 Dec 2023 (T+90)
5 of 5 declarations
About Beijing Tiantan Biological Products Co., Ltd.
Tian Tan Biological is a company in the healthcare and pharmaceutical sector, listed on the XSHG market. It focuses on the research and development of biological and pharmaceutical products.
